Molluscum Contagiosum (MC) Treatment Market Report 2026

Molluscum Contagiosum (MC) Treatment Market Overview

• Molluscum Contagiosum (MC) Treatment market size has reached to $3.1 billion in 2025 • Expected to grow to $4.07 billion in 2030 at a compound annual growth rate (CAGR) of 5.6% • Growth Driver: Growing Demand For Minimally Invasive Treatments In The Market • Market Trend: Innovative Topical Gel Solutions Driving Advancements In The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Molluscum Contagiosum (MC) Treatment Market?

Molluscum contagiosum (MC) treatment refers to the medical interventions and methods used to manage and resolve molluscum contagiosum, a viral skin infection caused by a poxvirus. The goal of treatment is to remove the characteristic lesions, prevent further spread of the virus, and alleviate any associated discomfort, although the infection often resolves on its own in healthy individuals. The main types of the molluscum contagiosum treatment are molluscum contagiosum virus-1, molluscum contagiosum virus-2, molluscum contagiosum virus-3, and molluscum contagiosum virus-4. Molluscum contagiosum virus-1 is the most prevalent subtype, accounting for 75–96% of cases, and primarily affects children through direct skin contact, causing self-limiting lesions on the face, trunk, and limbs. The treatment types include topical therapy, immune modulators, and procedural treatments. Drugs are administered through various routes, such as topical and oral, and are used by different end users, including hospitals, dermatology clinics, homecare settings, and others.

What Is The Molluscum Contagiosum (MC) Treatment Market Growth Forecast?

The molluscum contagiosum (mc) treatment market size is expected to see strong growth in the next few years. It will grow to $4.07 billion in 2030 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to rising demand for effective topical solutions, expansion of dermatology clinics, growing preference for minimally invasive treatments, increasing product innovation, rising adoption of home-based treatments. Major trends in the forecast period include development of precision-based dermatological therapies, integration of AI-driven diagnostic support tools, adoption of digital treatment monitoring platforms, expansion of automation in dermatology product manufacturing, increasing use of virtual consultation and remote care models.

Global Molluscum Contagiosum (MC) Treatment Market Segmentation

1) By Type: Molluscum Contagiosum Virus (MCV) -1, Molluscum Contagiosum Virus (MCV) -2, Molluscum Contagiosum Virus (MCV) -3, Molluscum Contagiosum Virus (MCV) -4 2) By Treatment Type: Topical Therapy, Immune-Modulators And Procedural Treatments 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Or E‑commerce 4) By End User: Hospitals, Dermatology Clinics, Homecare Settings, Other End Users

What Is The Driver Of The Molluscum Contagiosum (MC) Treatment Market?

The rising demand for minimally invasive treatments is expected to propel the growth of the molluscum contagiosum treatment market going forward. Minimally invasive treatments refer to medical procedures performed with minimal damage to the body, usually involving small incisions or no incisions. The demand for minimally invasive treatments is attributed to their ability to reduce recovery time, minimize surgical risks, and enhance patient outcomes compared to traditional procedures. Molluscum contagiosum treatment uses minimally invasive methods such as cryotherapy and laser therapy for effective removal, faster recovery, and less scarring. Minimally invasive treatments typically require fewer visits and are well-suited for treating the often widespread lesions in molluscum contagiosum. For instance, in February 2024, according to the American Academy of Facial Plastic and Reconstructive Surgery, a US-based non-profit organization, in 2023, minimally invasive procedures accounted for 83% of all medical procedures accounting for 35 million procedures in 2023, while traditional surgical procedures made up the remaining 17%. Therefore, the rising demand for minimally invasive treatments is driving the growth of the molluscum contagiosum treatment market.

Key Players In The Global Molluscum Contagiosum (MC) Treatment Market

Major companies operating in the molluscum contagiosum (mc) treatment market are Verrica Pharmaceuticals, Novan Inc., Veloce BioPharma LLC, Polaryx Therapeutics, Aclaris Therapeutics Inc., MedCara Pharmaceuticals LLC, Pelthos Therapeutics Inc., Veradermics, Arcutis Biotherapeutics, Krystal Biotech, Connect Biopharma, AbbVie Inc., Pfizer Inc., Johnson & Johnson, Galderma S.A., LEO Pharma, Amgen, DermBiont, Almirall, Tyris Therapeutics, Abeona Therapeutics, Fibrocell Science, Amryt Pharma, Azitra

Global Molluscum Contagiosum (MC) Treatment Market Trends and Insights

Major companies operating in the molluscum contagiosum (MC) treatment market are focusing on developing innovative products such as topical gel to enhance efficacy, improve patient compliance, and provide non-invasive treatment options. A topical gel is a semi-solid substance applied to the skin or mucous membranes for localized treatment or therapeutic effects. For instance, in April 2024, Ligand Pharmaceuticals Incorporated, a US-based biopharmaceutical company, launched Pelthos Therapeutics to commercialize Zelsuvmi (brazier) topical gel, 10.3%, the first Food and Drug Administration)-approved at-home treatment for molluscum contagiosum in adults and children over one-year-old. It is a nitric oxide-releasing gel designed to disrupt viral replication, leading to the clearance of lesions. Zelsuvmi offers a non-invasive, painless alternative to traditional in-office procedures such as cryotherapy or curettage, making it a practical and convenient option for patients aged one year and older.

What Are Latest Mergers And Acquisitions In The Molluscum Contagiosum (MC) Treatment Market?

In September 2023, Ligand Pharmaceuticals Incorporated, a US-based biopharmaceutical company, acquired Novan Inc. for $12.2 million. With this acquisition, Ligand Pharmaceuticals aims to preserve and maximize the value of Novan's commercial business and Berdazimer gel development assets. Novan Inc. is a US-based biotechnology company specializing in treating molluscum contagiosum (MC).

Regional Outlook

North America was the largest region in the molluscum contagiosum (MC) treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Molluscum Contagiosum (MC) Treatment Market?

The molluscum contagiosum (MC) treatment market includes revenues earned by entities by providing services such as cryotherapy, curettage, laser therapy, and photodynamic therapy, telemedicine and online consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Molluscum Contagiosum (MC) Treatment Market Report 2026?

The molluscum contagiosum (mc) treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the molluscum contagiosum (mc) treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.